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cluster size (ICS), which is the number of ionisations 
produced by a single particle within a specified volume. 
 
Results: In the figure the RBE-values for the two MXD is 
presented as a function of the distance from the source. For 
both sources the RBE decrease with increasing distance from 
the source. From the shape of the calculated spectra this can 
be explained by beam hardening effects. 
 
 
 
Conclusion: The determined RBE-values of 2.8 and higher can 
be traced back directly to the experimental data of E. 
Schmid as in the whole photon energy range from 4 – 50 keV 
the RBE was found to be higher than 2.6. This finding is in 
contrast to literature in which an enhanced RBE by 40 - 50% is 
reported and will be discussed taking the track structure into 
account. 
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Purpose or Objective: Molecular radiation therapy (MRT) has 
a long history of treating cancer by delivering a dose of 
radiation from a radioactively labelled pharmaceutical that is 
taken up by the tumour. At present the methods for 
determining the radiation dose to tissue are not traceable to 
any standards of absorbed dose. The determination of the 
internal absorbed dose from an administered radionuclide 
(RN) relies on Monte Carlo (MC) calculations based on nuclear 
data (emission probabilities and energies). The validation of 
these methods with experimental measurements is necessary 
to achieve the required traceability of the measurement of 
absorbed dose within the patient. The goal of this work is to 
develop a suitable method for measuring the absorbed dose 
from a RN solution that can serve as a primary standard. 
Comparison between measurements and calculations of 
absorbed dose in the same geometry will allow the validation 
of the MC dose calculation methods. 
 
Material and Methods: A modified extrapolation chamber 
(EC) was used for measuring the dose from a Y-90 RN 
solution. An EC is a suitable dosimeter as it has a thin 
entrance window allowing beta particle measurement and is 
capable of measuring low currents with small uncertainties. 
The volume of the chamber can be varied by changing the 
distance between the front and back faces. A phantom 
developed in-house was used to position the EC as closely as 
possible to the surface of the solution. The performance of 
the EC was characterised and a full uncertainty budget was 
obtained. The ionisation current was measured for different 
chamber volumes of the EC and a product of correction 
factors was applied to obtain the true current. MC 
simulations were performed to relate absorbed dose in the 
volume of the chamber to absorbed dose at the centre of the 
RN solution. This allows a direct comparison of the calculated 
and measured absorbed dose of Y-90 RN solution. The Y-90 
source emission spectra published by MIRD and RADAR were 
used to directly determine the calculated absorbed doses at 
the centre of the RN solution. 
 
Results: The overall standard uncertainty in the 
measurement of absorbed dose at the centre of a Y-90 
solution with the EC was determined to be in the range ±1.3% 
to ±1.6 % (k = 1). The calculated Y-90 absorbed dose from 
published MIRD and RADAR data agreed with measurement to 
within 1.6% and 1.5% respectively. 
 
Conclusion: These results demonstrate the feasibility of 
using an EC for performing primary standard absorbed dose 
measurements of an unsealed radioactive solution. Internal 
radiation dose assessment methods based on RADAR and MIRD 
data for Y-90 have been validated with experimental 
absorbed dose measurements and they agree within one 
standard uncertainty. Future work will include a repeat of Y-
90 measurements in order to further validate the present 
results and to extend the measurements to other RNs used 
for MRT. 
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Purpose or Objective: Stereotactic Radiosurgery modalities 
(SRS) allowing conformal dose distributions and adopting 
hypo-fractionation regimes require accurate Quality 
Assurance (QA) to avoid plan or operator mistakes. The QA of 
small field, multidirectional photon beams requires radiation 
dosimeters that have small sensitive volume, angular 
independent and operating in real time. The CMRP in 
collaboration with Advacam Ltd. has developed EDINA, an 
innovative silicon diode based probe, to meet the QA 
requirements of SRS. 
 
Material and Methods: The edgeless single diodes are 
manufactured using both n-type and p-type silicon substrates 
with 0.5 mm and 0.1 mm thicknesses. By using an ion 
implantation technique, four different configurations of top 
and peripheral p-n junctions are created. The Edgeless 
diodes’ samples are also fabricated with two different sizes 
(0.5×0.5 mm2 and 1×1 mm2) and embedded in Kapton tails 
with 0.5 mm thickness, 3mm width and 30 cm length using 
CMRP Drop-In Assembling technology, providing the dosimetry 
probe EDINA easy connected to electrometer. A full 
dosimetric characterisation of the radiation probes have been 
carried out. Output factor and angular dependence are 
measured by the edgeless detectors and compared with EBT3 
film under reference irradiation conditions. The dose rate 
and PDD measurements of EDINA have been performed in a 
solid water phantom whereas the angular dependence test 
was carried out in a cylindrical PMMA phantom, rotatable 
with accuracy of 0.25 degree. 
 
Results: The PDDs measured with EDINA on 6MV photon fields 
from 1.5 to 25 cm depth demonstrated an agreement with 
ion chambers within ±2%. The dose rate dependence in a 
range of 0.9×10−5 –2.7×10−4 Gy/pulse was less than −7% and 
+300% for EDINA with diodes fabricated on p-type and n-type 
substrates, respectively. Diodes fabricated on p-type and n-
type substrates demonstrated degradation of the response 
with accumulated dose of 40 kGy within 5% and 30%, 
respectively.  
The output factor measurements performed by EDINA 
utilizing smallest size diodes (0.5×0.5 mm2) show an 
agreement with film within 2% for square radiation field sizes 
ranging from 0.5 to 10 cm (Fig.1a). The angular response of 
EDINA utilizing thin 0.1mm thick smallest size p-type diodes 
(NP_100 and PP_100) varies within 2% (Fig.1b) between 0 and 
180 degree and independent from accumulated dose. 
 
